Logo

Tissue-Based Testing

News on immunohistochemistry and other tissue-based testing methods.

Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis

The end-to-end workflow products are intended for biopharmaceutical companies developing companion diagnostics for precision cancer therapeutics.

Functional Precision Medicine Firm Kiyatec Raises $18M in Series C Funding Round

The Clemson University spinout is developing live tissue-based models of cancer cells for use in predicting patients' individual drug responses.

Cofactor Genomics RNA-seq Assay Outperforms PD-L1 IHC to Predict Immunotherapy Responders
Premium

The firm is aiming to commercialize its OncoPrism assay in 2023 as a laboratory-developed test to identify head and neck cancer patients eligible for checkpoint inhibitors.

Oncgnostics Epigenetic Cervical Cancer Test Wins Chinese Regulatory Approval

The GynTect assay detects oncogenic DNA methylation markers from cervical smear samples following abnormal cancer-screen findings.

Bio-Techne Nabs CE Mark for HPV Head and Neck Cancer Test, Completes Namocell Acquisition

The RNAscope ISH Probe High Risk HPV test detects E6/E7 mRNA and is intended to help inform treatment selection in oropharyngeal squamous cell carcinoma patients.

Jun 3, 2022

Swiss Immunohistochemistry Firm Lunaphore Shifts Focus to High-Plex Spatial Proteomics
Premium

Jun 3, 2022

Foundation Medicine to Provide Comprehensive Genomic Profiling Tests in Lung Cancer Screening Trial

Jun 1, 2022

Max Planck Team Develops Workflow Combining Single-Cell Imaging With Deep Proteomic Profiling
Premium

May 11, 2022

Thermo Fisher Scientific Invests in Spatial Proteomics Firm Ionpath

Mar 22, 2022

Precision Medicine Firm PreludeDx Closes $20M Funding Round

Mar 8, 2022

Guardant Health Receives Medicare Coverage for Tissue-Based Cancer Test

Sep 9, 2021

RareCyte Secures $24M to Advance Spatial Biology Platform, Expand Globally

Jun 22, 2021

Guardant Health Targets Emerging Treatment Response Market With New ctDNA Product
Premium

Mar 9, 2021

Foundation Medicine, InformedDNA Partner to Expand Genetic Counseling for Cancer Patients

Mar 2, 2021

PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment
Premium

Jan 19, 2021

Blood, Urine Biomarker Study Leads to Linked Loci, Disease-Related Risk Scores

Dec 10, 2020

Spatial Analysis Startup Resolve Biosciences Launches With $24M Series A Financing Round

Nov 18, 2020

Indivumed, Ultivue Sign Deal to Integrate Cancer Tissue Analysis Technologies

Sep 22, 2020

Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug

Aug 21, 2020

Owkin Machine Learning Infers RNA Expression From Tissue Images in New Study
Premium

Jul 22, 2020

Ultivue, OracleBio Collaborate on Tissue Biomarker Analysis Workflow

Jul 17, 2020

RareCyte Targets Spatial Biology Market with New Orion Instrument
Premium

May 26, 2020

Bio-Techne, Leica Biosystems Receive CE Mark for Pathology Detection Kit, Platform

May 15, 2020

CareDx Hybrid Capture Tech for HLA Testing Receives CE Marking

Mar 11, 2020

DermTech Q4 Revenues Soar 152 Percent

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.